Using a large virtual screen comprised of current diabetes treatments as well as general ligand libraries the authors identified a number of novel binders of SOCS3, primarily for the SH2 domain, which would enable the inhibition of SOCS3’s activity (85). The gene discussed is SOCS3; the disease is diabetes mellitus.